Paper Details

  1. Home
  2. Paper Details

Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.

Author: AlmirallDaniel, Choate-SummersMolly, ComptonScott, EdsonAubrey L, FoaEdna B, FranklinMartin E, FreemanJennifer B, GarciaAbbe, KhannaMuniya, MarchJohn S, MoorePhoebe, SapytaJeffrey

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

In a 12-week randomized controlled trial of 124 children with OCD who had partial response to SRI use, those who received medication management plus CBT had a significantly greater response rate (68.6%) than those who received medication management only (30%) or medication management plus instructions in CBT (34%). This study suggests that CBT is an effective augmentation strategy for pediatric OCD patients who have not fully responded to SRI treatment.
Paper Details　
Original Abstract of the Article :
CONTEXT: The extant literature on the treatment of pediatric obsessive-compulsive disorder (OCD) indicates that partial response to serotonin reuptake inhibitors (SRIs) is the norm and that augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional benefit. OB...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21934055

データ提供：米国国立医学図書館（NLM）

Cognitive Behavior Therapy: A Powerful Tool for Pediatric OCD

This research investigates the effectiveness of cognitive behavior therapy (CBT) in augmenting pharmacotherapy for pediatric obsessive-compulsive disorder (OCD). The study conducted a randomized controlled trial involving children aged 7 to 17 years with OCD who showed partial response to serotonin reuptake inhibitors (SRIs). The results demonstrate that augmenting SRI treatment with CBT significantly improves response rates compared to medication management alone or with instructions in CBT.

CBT: A Key to Improving Outcomes in Pediatric OCD

The study found that the addition of CBT to medication management resulted in a significantly greater response rate in children with OCD who showed partial response to SRIs. The data suggests that CBT plays a crucial role in enhancing the effectiveness of pharmacotherapy for pediatric OCD. The study highlights the importance of incorporating CBT into treatment plans for children with OCD to improve outcomes and enhance their quality of life.

Unlocking the Power of CBT for Children with OCD

This research is a valuable contribution to our understanding of pediatric OCD and the role of CBT in treatment. It underscores the importance of a multi-faceted approach that combines medication and therapy. This study also reinforces the need to tailor treatment strategies to the individual needs of each child. We can help children with OCD live healthier and happier lives by embracing a holistic approach that includes both medication and therapy.

Dr.Camel's Conclusion

This study sheds light on the vital role of CBT in enhancing the effectiveness of medication for pediatric OCD. It is a reminder that a multi-faceted approach is key to improving the lives of children struggling with this challenging disorder.

Date :
  1. Date Completed 2011-09-23
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

21934055

DOI: Digital Object Identifier

NIHMS409960

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.